The impact of past alcohol use on treatment response rates in patients with chronic hepatitis C

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 8, 2005, Pages 701-706

  Chang, A ^a   Skole, K ^a   Gautam, M ^a   Schmutz, J ^a   Black, M ^a   Thomas, R ^a   Horwitz, B ^a   Friedenberg, F K ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; PEGINTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ANEMIA; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRINKING BEHAVIOR; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RASH; REGRESSION ANALYSIS; TREATMENT OUTCOME; TREATMENT REFUSAL; VIRUS LOAD;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALCOHOL DRINKING; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; ETHANOL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RIBAVIRIN; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 26944484392     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02631.x     Document Type: Article

References (18)

1. Alter M, Kruszon-Moran D, Nainan O, et al. The prevalence of hepatitis C infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
2. Bhattacharya R, Shuhart M. Hepatitis C and alcohol: interactions, outcomes and implications. J Clin Gastroenterol 2003; 36: 242-52.
3. Oshita M, Hayashi N, Kasahara A, et al. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Hepatology 1994; 27: 1730-5.
4. Okazaki T, Yoshihara H, Suzuki K, et al. Efficacy of interferon therapy in patients with chronic hepatitis C. A comparison between nondrinkers and drinkers. Scand J Gastroenterol 1994; 29: 1039-43.
5. Ohnishi K, Matsuo S, Matsutani K, et al. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol 1996; 91: 1374-9.
6. Tabone M, Sidoli L, Laudi C, et al. Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy. J Viral Hepat 2002; 9: 288-94.
7. Schaefer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003; 37: 443-51.
8. Fried M, Shiffman M, Reddy K, et al. Peg interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.
9. Mukamal K, Conigrave K, Mittleman M, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003; 348: 109-18.
10. Monto A, Patel K, Bostrom A, et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004; 39: 826-34.
11. Pearlman BL. Hepatitis C treatment update. Am J Med 2004; 117: 344-52.
12. Alcoholic Beverages; USDA Dietary Guidelines for Americans 2005. Available from: http://www.health.gov/dietaryguidelines/dga2005/document/html/ chapter9.htm
13. Hadziyannis S, Sette H Jr, Morgan T, et al. Peginterferon alfa-2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-55.
14. Muir A, Bornstein J, Killenberg P, et al. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med 2004; 350: 2265-71.
15. Kim WR, Potarucha JJ, Benson JT, Therneau TM. The impact of competing risks on the observed rate of hepatitis C progression. Gastroenterology 2004; 127: 749-55.
16. Mangia A, Santoro R, Minerva N, et al. Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3. N Engl J Med 2005; 352: 2609-17.
17. Bhattacharya R, Shuhart M. Hepatitis C and alcohol: interactions, outcomes, and implications. J Clin Gastroenterol 2003; 36: 242-52.
18. Safdar K, Schiff E. Alcohol and hepatitis C. Semin Liver Dis 2004; 24: 305-15.